1-20 of 8900
Sort by
Journal Article
ACCEPTED MANUSCRIPT
Moving towards precision and personalized treatment strategies in psychiatry
Stefano Comai and others
International Journal of Neuropsychopharmacology, pyaf025, https://doi.org/10.1093/ijnp/pyaf025
Published: 21 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Cigarette Smoking is Associated with Levels of the Serotonin Transporter in the Brain: A [11C]DASB PET Study
Paul Faulkner and others
International Journal of Neuropsychopharmacology, pyaf026, https://doi.org/10.1093/ijnp/pyaf026
Published: 21 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Distinct Effects of Psychiatric Disorder Diagnoses and Severe Emotional Dysregulation on Matrix Metalloproteinase-9, Proinflammatory Cytokines, and Inhibitory Control Function in Adolescents with Attention Deficit Hyperactivity Disorder or First-Episode Major Affective Disorders
Ju-Wei Hsu and others
International Journal of Neuropsychopharmacology, pyaf024, https://doi.org/10.1093/ijnp/pyaf024
Published: 12 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Addressing blinding in classic psychedelic studies with innovative active placebos
Jacob S Aday and others
International Journal of Neuropsychopharmacology, pyaf023, https://doi.org/10.1093/ijnp/pyaf023
Published: 04 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Association of driving with blood THC: A systematic review
D Behzad and others
International Journal of Neuropsychopharmacology, pyaf021, https://doi.org/10.1093/ijnp/pyaf021
Published: 02 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Association of Relapse With All-Cause Mortality in Adult Patients With Stable Schizophrenia
Christoph U Correll and others
International Journal of Neuropsychopharmacology, pyaf018, https://doi.org/10.1093/ijnp/pyaf018
Published: 01 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Sedative and Hypnotic Effects of Nuciferine: Enhancing Rodent Sleep via Serotonergic System Modulation
Luo-Xuan Wang and others
International Journal of Neuropsychopharmacology, pyaf019, https://doi.org/10.1093/ijnp/pyaf019
Published: 31 March 2025
Journal Article
ACCEPTED MANUSCRIPT
Lurasidone response in bipolar type I depression with childhood trauma exposure
Hernan F Guillen-Burgos and others
International Journal of Neuropsychopharmacology, pyaf020, https://doi.org/10.1093/ijnp/pyaf020
Published: 29 March 2025
Journal Article
ACCEPTED MANUSCRIPT
Premorbid Characteristics of the SAPAP3 Mouse Model of Obsessive-Compulsive Disorder: Behavior, Neuroplasticity, and Psilocybin Treatment
Michal Lazar and others
International Journal of Neuropsychopharmacology, pyaf022, https://doi.org/10.1093/ijnp/pyaf022
Published: 29 March 2025
Image
The rates of antipsychotic monotherapy and complete antipsychotic monothera...
Published: 28 March 2025
Figure 2.
The rates of antipsychotic monotherapy and complete antipsychotic monotherapy in the clozapine-available institution (CAI) group and the clozapine-unavailable institution (CUI) group when patients who were prescribed clozapine were excluded. (A) The rate of antipsychotic monotherapy in the CAI group
Image
The rates of antipsychotic monotherapy and complete antipsychotic monothera...
Published: 28 March 2025
Figure 1.
The rates of antipsychotic monotherapy and complete antipsychotic monotherapy between the clozapine-available institution (CAI) group and the clozapine-unavailable institution (CUI) group. (A) The rate of antipsychotic monotherapy in the CAI group was significantly higher than that in the CUI group.
Journal Article
Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide study
Shinichiro Ochi and others
International Journal of Neuropsychopharmacology, Volume 28, Issue 4, April 2025, pyaf011, https://doi.org/10.1093/ijnp/pyaf011
Published: 28 March 2025
Image
The rates of antipsychotic monotherapy and complete antipsychotic monothera...
Published: 28 March 2025
Figure 3.
The rates of antipsychotic monotherapy and complete antipsychotic monotherapy between the clozapine-available institution (CAI) group and the clozapine-unavailable institution (CUI) group, regardless of whether treatment-resistant schizophrenia subgroups were described. (A) The rate of antipsychotic
Journal Article
ACCEPTED MANUSCRIPT
Neuropathic Pain impairs Sleep Architecture, NREM sleep and Reticular Thalamic Neuronal activity
Martha López-Canul and others
International Journal of Neuropsychopharmacology, pyaf017, https://doi.org/10.1093/ijnp/pyaf017
Published: 23 March 2025
Journal Article
Examination of the relationship between D-amino acid profiles and cognitive function in individuals with mild cognitive impairment: a machine learning approach
Sou Sugiki and others
International Journal of Neuropsychopharmacology, Volume 28, Issue 4, April 2025, pyaf016, https://doi.org/10.1093/ijnp/pyaf016
Published: 15 March 2025
Image
Clinical trial flow. *In the comparison of the correlation between venous p...
Published: 15 March 2025
Figure 1.
Clinical trial flow. *In the comparison of the correlation between venous plasma and fingertip whole blood for D-Pro (%) or D-Ala (%), outliers are defined as those with standardized residuals exceeding 2.0.
Image
(A) Correlation comparison of amino acid concentrations in venous and finge...
Published: 15 March 2025
Figure 2.
(A) Correlation comparison of amino acid concentrations in venous and fingertip blood. Red dots indicate data points with outliers. (B) Correlation comparison of amino acid concentrations and D-amino acid (%) in venous and fingertip blood, excluding outliers.
Image
Scatterplots showing group differences in the concentration of D-Pro (%) an...
Published: 15 March 2025
Figure 3.
Scatterplots showing group differences in the concentration of D-Pro (%) and D-Ala (%) in whole fingertip blood. Black horizontal lines denote the median value. Differences in each concentration between the cognitively normal (CN) group and the suspected MCI group (MCI) by sex were explored using th
Image
(A) The ROC curve when a kernel SVM model was constructed using relatively ...
Published: 15 March 2025
Figure 4.
(A) The ROC curve when a kernel SVM model was constructed using relatively easily obtainable participant background information (sex, age, BMI, education years, number of people living together, and family composition), and LOOCV was performed. (B) The ROC curve when a kernel SVM model was construct
Image
(A) The ROC curve (kernel SVM, LOOCV) when the criterion for sus-MCI was se...
Published: 15 March 2025
Figure 5.
(A) The ROC curve (kernel SVM, LOOCV) when the criterion for sus-MCI was set to MMSE ≤ 26. (B) The ROC curve (kernel SVM, LOOCV) when the criterion for sus-MCI was set to MMSE ≤ 27. (C) The ROC curve (kernel SVM, LOOCV) when the borderline MMSE scores of 26 and 27 were excluded. LOOCV, leave-one-out
Advertisement
Advertisement